| Literature DB >> 23291270 |
Olöf Birna Kristjánsdóttir1, Egil A Fors, Erlend Eide, Arnstein Finset, Tonje Lauritzen Stensrud, Sandra van Dulmen, Sigrid Hørven Wigers, Hilde Eide.
Abstract
BACKGROUND: Internet-based interventions using cognitive behavioral approaches can be effective in promoting self-management of chronic pain conditions. Web-based programs delivered via smartphones are increasingly used to support the self-management of various health disorders, but research on smartphone interventions for persons with chronic pain is limited.Entities:
Mesh:
Year: 2013 PMID: 23291270 PMCID: PMC3636250 DOI: 10.2196/jmir.2249
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Study design and participant flow.
Examples of Acceptance and Commitment Therapy (ACT) elements in diaries and feedback.
| ACT element | Aim of diaries | Examples of diary questions | Aim of feedback | Examples of feedback |
| Cognitive defusion/ | Awareness supported by making diary entries on thoughts, feelings and behavior three times a day | (1) Right now, my breathing is deep and relaxed. (2) Right now, I believe it is harmful for me to use my body. (3) Right now, I am coping well with the pain. | Reflection on effects of thoughts and feelings on behavior | I see that you register that your breathing is not relaxed. Can you give yourself a minute or two to just notice your breathing? Maybe you can find a quiet spot and close your eyes. You could try breathing deeply and slowly a couple of times. Try focusing only on your breath. If you want, you can listen to the instructions to a short mindfulness breathing exercise on the smartphone/website. All the best, Ann. |
| Values and values-based action | Awareness, planning and evaluation supported by keeping a diary | Today, I plan to [multiple choices possible]: take a walk/work/rest lying down/do household chores/do relaxation exercises/take care of children or others/eat regularly/exercise at a moderate tempo/do my stretching exercises/spend time with family/rest sitting down/spend time with friends/do some shopping/do aerobic exercises/do something just for the pleasure of it. | Reflection on values and values-based behavior based on reports in diaries | I see you have done your stretching exercises today despite reporting a pain level of 6 (scale from 0 to 10; 0=no pain, 10=worst imaginable pain). Can you give yourself a moment to reflect on why this is something you value and choose to do? I would like to ask you to reflect again on your values, if you are willing to, over the next few days. Values are qualities we ourselves think are important and can give us a sense of direction in life. We can ask ourselves questions like: What kind of a person would I like to be in my relations with my family? What can I do today that would get me a bit closer to this ideal? Is this something I am willing to do? Our values are something we can continuously work toward (like being a caring friend), not something we will obtain once and for all. Have a nice weekend, Ann. |
| Acceptance vs avoidance | Awareness of a spectrum of pain-related thoughts, feelings, and behavior supported by keeping a diary | (1) Right now, I am afraid to be active because of my pain.” (2) Right now, I feel my life is good despite my pain. (3) Right now, I am doing what I want to even if it means increased pain. | Supporting willingness to act in accordance with values despite pain or discouraging thoughts and feelings | (1) I see that today you are not too pleased with your life. Can you give yourself a moment and reflect on what you would want to do today if you were pain free? Is it possible for you to take a small step toward what you want even with your pain? Could you, instead of saying, “I want this, BUT I have pain and therefore can’t” say “I experience pain AND I am taking baby steps toward something valuable to me.” Are you willing to take small steps? (2) Last night you reported a pain level of 8 and that you felt relaxed, grateful, and pleased with the day’s activity level. Can you take a moment to reflect on what kind of self-management strategies you used yesterday? All the best, Ann |
Figure 2Smartphone screen display of diary.
Participants’ characteristics at admission to the inpatient program (T1).
| Characteristic | Smartphone intervention | Control | |
| Age, mean (SD), n | 44.59 (11.13), 69 | 43.80 (11.20), 65 | |
|
|
|
| |
|
| Married or cohabiting | 42 (60.9) | 45 (68.2) |
| Divorced | 9 (13.0) | 6 (9.1) | |
| Single | 13 (18.8) | 10 (15.2) | |
| Widow | 4 (5.8) | 2 (3.0) | |
| Unknown | 1 (1.4) | 3 (4.5) | |
|
|
|
| |
|
| 10 years (elementary) | 13 (18.8) | 8 (12.1) |
| 11-13 years (high school) | 19 (27.5) | 30 (45.5) | |
| >13 years (college/university) | 30 (43.5) | 23 (34.8) | |
| Unknown | 7 (10.1) | 5 (7.6) | |
|
|
|
| |
|
| Working/studying | 15 (21.7) | 8 (12.1) |
| Unemployed | 3 (4.3) | 1 (1.5) | |
| On sick leave | 27 (39.1) | 34 (51.5) | |
| On disability pension | 12 (17.4) | 13 (19.7) | |
| Working/studying part time and part time sick leave | 8 (11.6) | 5 (7.6) | |
| Other combination of the above | 4 (5.8) | 4 (6.1) | |
| Unknown | 0 | 1 (1.5) | |
| Diagnosed with fibromyalgia, n (%) | 55 (80.9) | 54 (84.4) | |
| Duration of symptoms (years), mean (SD) | 13.11 (8.78) | 15.47 (12.09) | |
|
|
|
| |
|
| Pain | 67.08 (17.47), 69 | 57.85 (21.60), 66 |
| Fatigue | 67.40 (23.73), 69 | 64.72 (21.02), 66 | |
| Sleep disturbance | 57.24 (26.22) 68 | 55.16 (23.38), 66 | |
|
|
|
| |
|
| PCS (0-52d) | 21.24 (10.33), 63 | 20.80 (9.45), 62 |
|
| CPAQ (0d-120) | 56.48 (15.02), 58 | 53.87 (13.81), 57 |
|
| FIQ (0-100d) | 58.75 (16.39), 69 | 58.58 (16.04), 66 |
|
| SF-8, physical (0d-100) | 31.91 (7.57), 65 | 34.75 (7.35), 62 |
|
| SF-8, mental (0d-100) | 39.33 (10.49), 65 | 39.34 (9.61), 62 |
|
| GHQ-12 (0-12d) | 3.32 (3.38), 62 | 3.02 (3.38), 61 |
|
| CPVI (0d-6) | 2.07 (0.95), 64 | 2.01 (0.73), 61 |
a Patients meeting exclusion criteria after randomization were not included in this analysis.
b VAS: visual analog scale, range 0-100.
c PCS: pain catastrophizing scale; CPAQ: Chronic Pain Acceptance Questionnaire; FIQ: Fibromyalgia Impact Questionnaire; SF-8: Short-Form Health Survey; GHQ-12: General Health Questionnaire; and CPVI: Chronic Pain Values Inventory.
d Values that indicate maximum symptom scores/least health.
Means and standard deviations for the primary outcome measure, the pain catastrophizing scale (PCS), at admission to inpatient rehabilitation (T1), at discharge (T2), immediately after intervention (T3), and 5 months after the intervention period (T4).
| PCS | T1 | T2 | T3 | T4 | |
|
|
|
|
|
| |
|
| Intervention | 21.24 (10.33), 63 | 16.06 (10.37), 68 | 12.32 (9.22), 69 | 13.59 (9.72), 69 |
|
| Control | 20.80 (9.45), 62 | 15.33 (9.31), 65 | 16.07 (9.48), 65 | 17.43 (11.60), 66 |
|
|
|
|
|
| |
|
| Intervention | 20.56 (10.08), 43 | 14.61 (8.93), 45 | 9.20 (5.85), 47 | 10.92 (8.58), 37 |
|
| Control | 20.78 (9.59), 60 | 15.46 (9.76), 57 | 15.71 (9.11), 37 | 18.70 (12.45), 40 |
|
|
|
|
|
| |
|
| Intervention | 13 (30.2) | 7 (15.6) | 0 (0) | 1 (2.7) |
|
| Control | 20 (33.3) | 10 (17.5) | 6 (16.7) | 14 (35.0) |
a ITT: intention-to-treat; LOCF: last observation carried forward.
Means and standard deviations for the secondary outcome measures at admission to the inpatient rehabilitation (T1), at discharge (T2), immediately after intervention (T3) and 5 months after the intervention period (T4) for the participants who completed the study.
| Secondary outcome measuresa
| T1 | T2 | T3 | T4 | |
|
|
|
|
|
| |
|
| Intervention | 56.45 (15.22), 40 | 62.00 (13.62), 44 | 72.50 (15.67), 44 | 71.42 (18.38), 36 |
| Control | 53.94 (13.92), 56 | 62.21 (10.15), 57 | 63.55 (13.33), 38 | 62.47 (14.87), 38 | |
|
|
|
|
|
| |
|
| Intervention | 58.46 (17.26), 48 | 46.38 (16.92), 47 | 49.12 (19.65), 47 | 46.45 (19.37), 37 |
|
| Control | 58.35 (16.18), 64 | 49.10 (17.32), 62 | 53.07 (18.68), 39 | 59.92 (16.46), 40 |
|
|
|
|
|
| |
|
| Intervention | 32.12 (7.74), 45 | 36.68 (8.42), 40 | 35.24 (8.74), 46 | 37.54 (9.44), 37 |
|
| Control | 34.98 (7.13), 60 | 35.86 (8.24), 49 | 36.55 (8.17), 37 | 34.37 (8.59), 40 |
|
|
|
|
|
| |
|
| Intervention | 39.50 (10.67), 45 | 45.70 (8.06), 40 | 46.82 (8.85), 47 | 44.34 (10.42), 37 |
|
| Control | 39.09 (9.61), 60 | 44.83 (9.69), 49 | 41.01 (9.70), 37 | 39.78 (10.70), 40 |
|
|
|
|
|
| |
|
| Intervention | 3.19 (3.21), 43 | 1.20 (2.02), 45 | 1.78 (2.51), 46 | 1.89 (2.57), 37 |
|
| Control | 2.97 (3.43), 59 | 0.63 (1.01), 57 | 1.86 (2.07), 37 | 2.85 (3.25), 40 |
|
|
|
|
|
| |
|
| Intervention | 2.05 (0.95), 44 | 2.47 (0.91), 46 | 2.95 (0.99), 46 | 2.62 (0.93), 37 |
|
| Control | 2.02 (0.74), 59 | 2.52 (0.68), 54 | 2.35 (0.91), 38 | 2.27 (0.83), 40 |
|
|
|
|
|
| |
|
| Intervention | 66.59 (17.58), 48 | 53.07 (22.20), 47 | 54.14 (24.06), 47 | 51.96 (23.76), 37 |
|
| Control | 57.32 (21.56), 64 | 52.99 (21.27), 61 | 50.56 (23.37), 40 | 58.45 (22.46), 40 |
|
|
|
|
|
| |
|
| Intervention | 69.29 (23.98), 48 | 51.38 (27.75), 47 | 52.26 (29.18), 47 | 55.24 (25.73), 37 |
|
| Control | 64.08 (21.01), 64 | 50.10 (24.28), 61 | 53.20 (24.04), 40 | 65.03 (21.64), 40 |
|
|
|
|
|
| |
|
| Intervention | 54.77 (26.99), 47 | 43.97 (25.77), 47 | 43.41 (30.60), 47 | 43.32 (27.88), 37 |
|
| Control | 54.59 (23.31), 64 | 48.12 (24.57), 62 | 48.90 (26.12), 40 | 57.68 (24.67), 40 |
a CPAQ: Chronic Pain Acceptance Questionnaire; FIQ: Fibromyalgia Impact Questionnaire; SF-8: Short-Form Health Survey; GHQ-12: General Health Questionnaire; CPVI: Chronic Pain Values Inventory; and VAS: visual analog scale.
Mean differences for the primary outcome measure, the pain catastrophizing scale (PCS) within groups, confidence intervals (CI), and effect sizes (ES).
| PCS | Mean difference | 95% CI | Mean difference | 95% CI | ES |
| ES |
| |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | –3.65 (68) | –5.24 to –2.07 | –2.37 (68) | –4.32 to –0.41 | 0.37 | < .001 | 0.24 | .02 |
|
| Control | 0.74 (65) | –0.70 to 2.17 | 2.30 (65) | 0.43-4.16 | –0.08 | .31 | –0.22 | .02 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | –5.09 (44) | –7.00 to –3.18 | –2.96 (36) | –5.78 to –0.13 | 0.69 | < .001 | 0.33 | .04 |
|
| Control | 1.67 (34) | –1.06 to 4.40 | 2.58 (37) | –0.37 to 5.53 | –0.18 | .22 | –0.24 | .09 |
a T2: at discharge; T3: immediately after intervention.
b T2: at discharge; T4: 5 months after intervention.
c P values for paired samples t tests.
d ITT: intention-to-treat; LOCF: last observation carried forward.
Mean differences for the secondary outcome measures within groups, confidence intervals (CI), and effect sizes (ES) for the completers.
| Secondary outcome measuresa | Mean difference | 95% CI | Mean difference | 95% CI | ES |
| ES |
| |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 8.75 (40) | 5.96-11.54 | 7.29 (34) | 3.11-11.47 | 0.58 | < .001 | 0.45 | .001 |
|
| Control | 0.69 (36) | –2.90 to 4.29 | 0.40 (35) | –3.43 to 4.23 | 0.06 | .70 | 0.03 | .83 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 3.10 (46) | –1.01 to 7.20 | 1.60 (36) | –4.40 to 7.60 | –0.17 | .14 | –0.09 | .59 |
|
| Control | 6.61 (38) | 2.14-11.09 | 10.46 (39) | 6.43-14.49 | –0.36 | .005 | –0.62 | < .001 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | –1.69 (39) | –3.96 to 0.59 | 0.06 (30) | –3.73 to 3.86 | –0.19 | .14 | 0.01 | .97 |
|
| Control | –1.17 (29) | –4.18 to 1.83 | –2.41 (32) | –5.17 to 0.36 | –0.14 | .43 | –0.29 | .09 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 1.28 (39) | –1.72 to 4.28 | –1.51 (30) | –4.93 to 1.92 | 0.15 | .39 | –0.17 | .38 |
|
| Control | –3.59 (29) | –7.04 to –0.14 | –4.92 (32) | –9.55 to –0.30 | –0.37 | 0.04 | –0.50 | .04 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 0.58 (43) | –0.06 to 1.22 | 0.80 (35) | –0.42 to 2.02 | –0.25 | .07 | –0.34 | .19 |
|
| Control | 1.26 (34) | 0.59-1.94 | 2.38 (37) | 1.12-3.63 | –0.80 | .001 | –1.09 | < .001 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 0.49 (44) | 0.26-0.72 | 0.15 (36) | –0.11 to 0.42 | 0.52 | < .001 | 0.16 | .25 |
|
| Control | –0.22 (33) | –0.49 to 0.06 | –0.47 (34) | –0.83 to –0.10 | –0.28 | 0.12 | –0.63 | .01 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 1.11 (46) | –3.94 to 6.16 | 0.61 (36) | –7.03 to 8.24 | –0.05 | .66 | –0.03 | .87 |
|
| Control | –0.99 (38) | –7.48 to 5.50 | 5.82 (38) | –1.26 to 12.90 | 0.04 | .76 | –0.26 | .10 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | 1.13 (46) | –4.94 to 7.21 | 7.73 (36) | –2.26 to 17.72 | –0.04 | .71 | –0.29 | .13 |
|
| Control | 5.44 (38) | –1.13 to 12.01 | 12.15 (38) | 6.29-18.00 | –0.22 | .10 | –0.51 | < .001 |
|
|
|
|
|
|
|
|
|
| |
|
| Intervention | –0.14 (46) | –7.03 to 6.76 | 2.15 (36) | –7.81-12.12 | 0.01 | .97 | –0.08 | .66 |
|
| Control | 3.96 (39) | –5.42 to 13.33 | 7.66 (39) | –0.62 to 15.95 | –0.15 | .40 | –0.30 | .07 |
a CPAQ: Chronic Pain Acceptance Questionnaire; FIQ: Fibromyalgia Impact Questionnaire; SF-8: Short-Form Health Survey; GHQ-12: General Health Questionnaire; CPVI: Chronic Pain Values Inventory; and VAS: visual analog scale.
b T2: at discharge; T3: immediately after intervention.
c T2: at discharge; T4: 5 months after intervention.
d P values for paired samples t tests.
Between-group effect sizes (ES) after the smartphone intervention (T3) and at 5-month follow-up (T4).
| Outcome measurea | ES at T3 |
| ES at T4 |
| |
|
|
|
|
|
| |
|
| PCS (ITT and LOCF) | 0.40 | .01 | 0.36 | .05 |
|
| PCS (per protocol) | 0.87 | < .001 | 0.74 | .003 |
|
|
|
|
|
| |
|
| CPAQ | 0.62 | .007 | 0.54 | .02 |
|
| FIQ | 0.21 | .35 | 0.75 | .001 |
|
| SF-8, physical | –0.15 | .64 | 0.35 | .13 |
|
| SF-8, mental | 0.63 | .005 | 0.43 | .06 |
|
| GHQ-12 | 0.03 | .56 | 0.33 | .16 |
|
| CPVI | 0.63 | .005 | 0.40 | .08 |
|
| Pain, VAS | –0.15 | .49 | 0.28 | .22 |
|
| Fatigue, VAS | 0.04 | .87 | 0.41 | .07 |
|
| Sleep disturbance, VAS | 0.19 | .36 | 0.55 | .02 |
a PCS: pain catastrophizing scale; ITT: intention-to-treat; LOCF: last observation carried forward; CPAQ: Chronic Pain Acceptance Questionnaire; FIQ: Fibromyalgia Impact Questionnaire; SF-8: Short-Form Health Survey; GHQ-12: General Health Questionnaire; CPVI: Chronic Pain Values Inventory; and VAS: visual analog scale.
b P values for independent t tests or nonparametric tests.